A Comparative Analysis of Adjunctive Transmyocardial Laser Revascularization With Coronary Artery Bypass Grafting

Ishan Deshmukh1, Constantino G Lambroussis2

  • 1Vascular Surgery, Lake Erie College of Osteopathic Medicine, Elmira, USA.

Cureus
|April 21, 2025
PubMed

Insights

Transmyocardial laser revascularization (TMLR) combined with coronary artery bypass grafting (CABG) offers short-term angina relief and improved outcomes for coronary artery disease (CAD) patients. Long-term benefits may diminish after one year.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Medical Technology

Background:

  • Coronary artery disease (CAD) is a major global health issue, causing significant morbidity and mortality.
  • Plaque buildup in coronary arteries restricts blood flow, leading to chest pain and shortness of breath.
  • Current CAD management includes lifestyle changes, medications, and revascularization procedures like CABG, PCI, and TMLR.

Purpose of the Study:

  • To evaluate the short-term and long-term benefits of transmyocardial laser revascularization (TMLR) as an adjunct to coronary artery bypass grafting (CABG) for angina severity in CAD patients.
  • To compare clinical outcomes of TMLR + CABG versus CABG alone.

Main Methods:

  • A systematic literature search and meta-analysis were conducted using PubMed, BioMed Central, and ClinicalTrials.gov databases.
  • Studies were included from database inception to February 2023, adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
  • Analysis focused on angina severity, length of stay, operative mortality, and long-term outcomes.

Main Results:

  • Adjunctive TMLR + CABG significantly reduces angina severity in the short term compared to CABG alone.
  • Patients receiving TMLR + CABG experienced shorter intensive care unit and hospital stays, and reduced operative mortality.
  • Superior angina relief was observed in the TMLR + CABG group in the short term.

Conclusions:

  • Transmyocardial laser revascularization (TMLR) as an adjunct to coronary artery bypass grafting (CABG) provides significant short-term clinical benefits for coronary artery disease (CAD) patients.
  • While short-term outcomes are favorable, the sustained benefits of TMLR + CABG beyond one year require further investigation.
  • Additional research is recommended to fully understand the long-term efficacy and patient outcomes associated with adjunctive TMLR in CAD management.